Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Kadmon Holdings Llc (KDMN)

Kadmon Holdings Llc (KDMN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 586,203
  • Shares Outstanding, K 129,691
  • Annual Sales, $ 1,400 K
  • Annual Income, $ -54,250 K
  • 60-Month Beta 2.47
  • Price/Sales 608.84
  • Price/Cash Flow N/A
  • Price/Book 15.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.17
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +62.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.15 +8.92%
on 01/15/20
5.09 -11.20%
on 02/04/20
+0.31 (+7.36%)
since 01/14/20
3-Month
3.75 +20.53%
on 11/15/19
5.38 -15.99%
on 12/12/19
+0.60 (+15.31%)
since 11/14/19
52-Week
1.63 +177.30%
on 06/25/19
5.38 -15.99%
on 12/12/19
+2.26 (+100.00%)
since 02/14/19

Most Recent Stories

More News
Kadmon Announces Acceptance of Late-Breaking Abstract of KD025 for cGVHD at the 2020 TCT Meetings

NEW YORK, NY / ACCESSWIRE / January 10, 2020 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced that expanded data from the interim analysis of ROCKstar (KD025-213), its ongoing pivotal trial of KD025...

KDMN : 4.52 (-2.38%)
Implied Volatility Surging for Kadmon (KDMN) Stock Options

Investors need to pay close attention to Kadmon (KDMN) stock based on the movements in the options market lately.

KDMN : 4.52 (-2.38%)
Kadmon and Meiji Announce Collaboration to Develop and Commercialize KD025 in Japan

NEW YORK, NY and TOKYO, JAPAN / ACCESSWIRE / December 26, 2019 / Kadmon Holdings, Inc. (NYSE:KDMN), a New York-based biopharmaceutical company, and Meiji Seika Pharma Co., Ltd, a Tokyo-based wholly owned...

KDMN : 4.52 (-2.38%)
Kadmon to Present Updated Data from Phase 2 Study of KD025 in cGVHD at the 61st ASH Annual Meeting & Exposition

NEW YORK, NY / ACCESSWIRE / December 3, 2019 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced that longer-term follow-up results from KD025-208, its ongoing Phase 2 study of KD025 in chronic graft-versus-host...

KDMN : 4.52 (-2.38%)
Kadmon Announces Closing of $101.6mm Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares

NEW YORK, NY / ACCESSWIRE / November 18, 2019 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced the closing of its previously announced underwritten public offering of 29,900,000 shares of common stock...

KDMN : 4.52 (-2.38%)
Kadmon to Participate in Upcoming Investor Conferences

NEW YORK, NY / ACCESSWIRE / November 18, 2019 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present at the following investor...

KDMN : 4.52 (-2.38%)
Kadmon Announces Pricing of Public Offering of Common Stock

NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) ("Kadmon") today announced the pricing of an offering of 26,000,000 shares of its common stock at a public offering price...

KDMN : 4.52 (-2.38%)
Kadmon Announces Proposed Public Offering of Common Stock

NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) ("Kadmon") today announced its intention to offer and sell shares of its common stock in a public offering pursuant to...

KDMN : 4.52 (-2.38%)
Today's New Way to Fight Cancer Focusing on Metabolic Therapies

For decades researchers have been trying to find newer and more effective ways to fight cancer cells. Today much research is focused on attacking the cancerous cells growth. The reasoning is that denying...

MBRX : 0.76 (+5.41%)
AMRN : 17.62 (-0.40%)
KDMN : 4.52 (-2.38%)
PFE : 36.51 (-1.14%)
ACST : 0.57 (-1.55%)
ACST.VN : 0.760 (unch)
Kadmon Announces that KD025 Met Primary Endpoint at Interim Analysis of Pivotal Trial in Chronic Graft-Versus-Host Disease

KD025 Achieved ORRs of 64% with KD025 200 mg QD and 67% with KD025 200 mg BID Conference Call Today at 5:00 p.m. Eastern Time

KDMN : 4.52 (-2.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade KDMN with:

Business Summary

Kadmon Holdings, Inc. is a biopharmaceutical company. It engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of significant unmet medical need. The company is developing product candidates within autoimmune and fibrotic diseases, oncology...

See More

Key Turning Points

2nd Resistance Point 4.68
1st Resistance Point 4.60
Last Price 4.52
1st Support Level 4.47
2nd Support Level 4.42

See More

52-Week High 5.38
Last Price 4.52
Fibonacci 61.8% 3.95
Fibonacci 50% 3.51
Fibonacci 38.2% 3.06
52-Week Low 1.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar